Phospho-OXSR1 (T185) Antibody

What is the specificity of Phospho-OXSR1 (T185) Antibody?

Phospho-OXSR1 (T185) Antibody specifically detects endogenous levels of OXSR1 (Oxidative-stress responsive 1) protein only when phosphorylated at Threonine 185. The antibody binds to a peptide derived from human OXSR1 around the phosphorylation site, typically in the amino acid range 151-200. This antibody does not recognize the unphosphorylated form of OXSR1, making it ideal for studying the activation state of this kinase . The phospho-specificity is critical for monitoring OXSR1 activation in response to upstream WNK kinases and subsequent downstream signaling events in the WNK-SPAK/OSR1 cascade .

What are the technical specifications of commercially available Phospho-OXSR1 (T185) Antibodies?

Current commercially available Phospho-OXSR1 (T185) Antibodies share several key specifications, though some variation exists between manufacturers:

These antibodies are typically affinity-purified from rabbit antiserum using epitope-specific immunogen chromatography to ensure high specificity .

What is the biological function of OXSR1 and why is its phosphorylation important?

OXSR1 functions as an effector serine/threonine-protein kinase within the WNK-SPAK/OSR1 kinase cascade. This pathway is crucial for:

• Ion transport regulation via phosphorylation of cotransporters (SLC12A1/NKCC2, SLC12A2/NKCC1, SLC12A3/NCC, and KCC transporters)

• Response to hypertonic stress and cell volume homeostasis

• Blood pressure regulation through effects on renal salt handling

Phosphorylation at Thr185 by WNK kinases (WNK1, WNK2, WNK3, or WNK4) is absolutely required for OXSR1 activation. Once phosphorylated, OXSR1 undergoes a conformational change that enables it to specifically recognize and bind proteins containing an RFXV motif, subsequently phosphorylating downstream targets . Autophosphorylation further promotes its activity. This cascade is critical in multiple physiological contexts, including kidney function, neuronal excitability, and cell volume regulation .

What applications are recommended for Phospho-OXSR1 (T185) Antibody and what are optimal dilution ranges?

Phospho-OXSR1 (T185) Antibody has been validated for multiple research applications, each requiring specific optimization:

These ranges serve as starting points; optimal concentrations should be determined empirically for each experimental system and sample type . For Western blot applications using cell lysates, the 1:500-1:1000 range typically provides the best balance of specific signal and background reduction .

How can I validate the phospho-specificity of the Phospho-OXSR1 (T185) Antibody?

To ensure the phospho-specificity of the antibody, a rigorous validation protocol should be followed:

• Phosphatase Treatment Test:

  • Divide your protein lysate (containing phosphorylated OXSR1) into two equal portions

  • Treat one portion with bovine intestinal phosphatase (or similar phosphatase)

  • Leave the other portion untreated (control)

  • Run both samples on SDS-PAGE and perform immunoblotting

  • A truly phospho-specific antibody will show signal only in the untreated sample

• Stimulation/Inhibition Controls:

  • Use samples from cells treated with osmotic stressors known to induce OXSR1 phosphorylation (positive control)

  • Include samples from cells treated with WNK kinase inhibitors to prevent phosphorylation (negative control)

  • Compare signal intensity between conditions

• Immunogen Peptide Competition:

  • Pre-incubate the antibody with the phosphopeptide used as immunogen

  • This should abolish specific binding in subsequent assays

This validation approach is similar to protocols used for other phospho-specific antibodies and ensures that the antibody truly discriminates between phosphorylated and non-phosphorylated forms of OXSR1 .

How should I design a Western blot experiment to detect phosphorylated OXSR1?

For optimal Western blot detection of phosphorylated OXSR1:

• Sample Preparation:

  • Extract proteins in buffer containing phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate)

  • Process samples quickly and maintain at 4°C to prevent dephosphorylation

  • Use fresh or properly stored (-80°C) samples; avoid repeated freeze-thaw cycles

• Gel Electrophoresis:

  • Load 20-50 μg of total protein per lane

  • Use 8-10% acrylamide gels for optimal resolution of the 65-72 kDa OXSR1 protein

  • Include molecular weight markers spanning 50-100 kDa range

• Transfer and Blocking:

  • Transfer to PVDF membrane (preferred over nitrocellulose for phosphoproteins)

  • Block with 5% BSA in TBST (not milk, which contains phosphoproteins that may interfere)

  • Block for 1 hour at room temperature or overnight at 4°C

• Antibody Incubation:

  • Dilute primary antibody in 5% BSA/TBST at recommended concentration (1:500-1:2000)

  • Incubate overnight at 4°C with gentle agitation

  • Wash extensively with TBST (at least 3 x 10 minutes)

  • Use appropriate HRP-conjugated secondary antibody (typically anti-rabbit IgG)

• Detection and Controls:

  • Use enhanced chemiluminescence detection

  • Always include phosphatase-treated control sample

  • Run parallel blot with total OXSR1 antibody for normalization

  • Include loading control (β-actin, GAPDH, etc.)

This methodical approach ensures reliable and reproducible detection of phosphorylated OXSR1 .

How can I design experiments to study OXSR1 phosphorylation in response to osmotic stress?

To comprehensively study OXSR1 phosphorylation in response to osmotic stress:

• Cell Model Selection:

  • Choose cell lines with detectable endogenous OXSR1 expression (renal epithelial cells like HEK293, mpkCCD, or neuronal cells)

  • Consider using models relevant to physiological contexts where OXSR1 functions

• Stress Induction Protocol:

  • Prepare hypertonic solutions (e.g., NaCl, sorbitol, mannitol)

  • Design dose-response experiments (300-500 mOsm/kg range)

  • Perform time-course analysis (5 minutes to 24 hours) to capture rapid phosphorylation and potential adaptation

• Experimental Groups:

  • Untreated control

  • Osmotic stress conditions (multiple concentrations)

  • WNK kinase inhibitor + osmotic stress

  • Phosphatase treatment control

  • Recovery after stress (return to isotonic media)

• Analysis Methods:

  • Western blot with Phospho-OXSR1 (T185) and total OXSR1 antibodies

  • Immunofluorescence to assess subcellular localization changes

  • Kinase activity assays using purified substrates

  • Functional assays (ion flux measurements, cell volume regulation)

• Data Analysis:

  • Quantify phospho-OXSR1/total OXSR1 ratio

  • Correlate phosphorylation with functional outcomes

  • Analyze kinetics of phosphorylation and dephosphorylation

This experimental design allows for comprehensive characterization of OXSR1 activation in response to osmotic challenges and helps elucidate its role in cellular adaptation mechanisms .

What controls are critical when using Phospho-OXSR1 (T185) Antibody in immunofluorescence studies?

For rigorous immunofluorescence studies with Phospho-OXSR1 (T185) Antibody:

• Essential Controls:

  • Positive Control: Cells treated with known activators of OXSR1 phosphorylation (hyperosmotic stress)

  • Negative Control: Omission of primary antibody to assess secondary antibody specificity

  • Phosphatase Control: Cells treated with phosphatase inhibitors vs. cells without inhibitors

  • Peptide Competition: Pre-incubation of antibody with immunizing phosphopeptide to confirm specificity

  • Knockdown/Knockout Control: siRNA or CRISPR-mediated OXSR1 reduction to validate signal specificity

• Validation Parameters:

  • Signal localization should match known subcellular distribution of active OXSR1

  • Signal intensity should increase with treatments known to activate WNK-OXSR1 pathway

  • Signal should be absent or significantly reduced in negative controls

  • Co-localization with known OXSR1 interaction partners provides additional validation

• Documentation Requirements:

  • All controls should be processed identically to experimental samples

  • Image acquisition settings must be consistent across all samples

  • Include scale bars and maintain consistent magnification

  • Document both merged and individual channel images

These controls ensure that the observed immunofluorescence signal truly represents phosphorylated OXSR1 rather than non-specific binding or artifacts .

How can I optimize immunohistochemistry protocols for detecting phosphorylated OXSR1 in tissue sections?

Optimizing immunohistochemistry for phosphorylated OXSR1 detection requires attention to several critical parameters:

• Tissue Processing Considerations:

  • Use freshly collected tissues fixed immediately in 10% neutral buffered formalin (12-24 hours)

  • Avoid overfixation which can mask phospho-epitopes

  • Process tissues carefully to preserve phosphorylation status

  • Cut sections at 4-5 μm thickness for optimal antibody penetration

• Antigen Retrieval Optimization:

  • Test multiple methods: citrate buffer (pH 6.0) vs. EDTA buffer (pH 9.0)

  • Compare pressure cooker vs. microwave heating methods

  • Optimize retrieval duration (10-30 minutes)

  • Allow slides to cool slowly to room temperature (20 minutes)

• Blocking and Antibody Incubation:

  • Block with 5% BSA or commercial protein blocker (30-60 minutes)

  • Test antibody dilutions across recommended range (1:50-1:300)

  • Optimize incubation time and temperature (overnight at 4°C often yields best results)

  • Consider using amplification systems for weak signals

• Detection System Selection:

  • For chromogenic detection, polymer-HRP systems typically provide best sensitivity

  • For fluorescent detection, tyramide signal amplification may enhance sensitivity

  • Optimize DAB development time (2-10 minutes) with microscopic monitoring

• Validation Strategy:

  • Include known positive tissue controls (kidney cortex typically shows OXSR1 expression)

  • Use phosphatase-treated serial sections as negative controls

  • Compare staining patterns with published literature on OXSR1 expression

This systematic approach should yield reliable and reproducible phospho-OXSR1 immunohistochemical staining suitable for both research and potential clinical applications .

How can I troubleshoot weak or absent signal when using Phospho-OXSR1 (T185) Antibody?

When facing weak or absent signal with Phospho-OXSR1 (T185) Antibody, consider these systematic troubleshooting approaches:

• Sample-Related Issues:

  • Problem: Insufficient phosphorylation of OXSR1

    • Solution: Verify stimulus effectiveness; increase stimulus intensity/duration

  • Problem: Dephosphorylation during sample preparation

    • Solution: Ensure complete phosphatase inhibitor coverage; maintain samples at 4°C

• Antibody-Related Issues:

  • Problem: Antibody degradation or denaturation

    • Solution: Test new antibody aliquot; validate with known positive control

  • Problem: Suboptimal antibody concentration

    • Solution: Perform antibody titration; consider using more concentrated solution

• Protocol-Related Issues:

  • Problem: Inadequate antigen retrieval (for IHC/IF)

    • Solution: Optimize retrieval method, buffer, and duration

  • Problem: Inefficient blocking

    • Solution: Extend blocking time; try alternative blocking reagents

  • Problem: Insufficient incubation time

    • Solution: Extend primary antibody incubation (overnight at 4°C)

• Detection-Related Issues:

  • Problem: Low sensitivity detection system

    • Solution: Switch to more sensitive detection method

  • Problem: Membrane type incompatibility (for WB)

    • Solution: Try PVDF instead of nitrocellulose

• Validation Steps:

  • Run positive control known to express phosphorylated OXSR1

  • Verify antibody activity with dot blot using immunizing phosphopeptide

  • Test alternative detection methods or more sensitive reagents

This structured approach helps identify the source of the problem and implement appropriate solutions to improve phospho-OXSR1 detection .

What strategies can minimize non-specific binding when using Phospho-OXSR1 (T185) Antibody?

To minimize non-specific binding and improve signal-to-noise ratio with Phospho-OXSR1 (T185) Antibody:

• Blocking Optimization:

  • Use 5% BSA instead of milk (milk contains phosphoproteins that may interfere)

  • Extend blocking time to 2 hours at room temperature

  • Add 0.1-0.3% Triton X-100 for better penetration in IF/IHC

  • Consider adding 5% normal serum matching secondary antibody species

• Antibody Dilution Refinement:

  • Titrate antibody carefully to find minimal concentration giving specific signal

  • Prepare antibody in fresh blocking solution

  • Pre-adsorb antibody with tissue powder from negative control tissue

• Washing Protocol Enhancement:

  • Increase number of washes (5-6 times instead of 3)

  • Extend wash duration (10-15 minutes each)

  • Use higher detergent concentration in wash buffer (0.1% Tween-20)

  • Ensure complete buffer removal between wash steps

• Sample Quality Improvement:

  • Use fresh tissues/cells and process immediately

  • Clarify lysates thoroughly before use (high-speed centrifugation)

  • Filter antibody solutions before use to remove aggregates

• Advanced Techniques:

  • Consider using monovalent Fab secondary antibodies

  • Employ two-step detection systems for increased specificity

  • For IF, use spectral unmixing to separate specific signal from autofluorescence

These strategies can significantly improve the signal-to-noise ratio and enhance the specificity of Phospho-OXSR1 (T185) Antibody across different applications .

How should I validate antibody quality after storage or between experimental batches?

To ensure consistent antibody performance and validate quality between experimental batches:

• Standard Quality Control Protocol:

  • Create aliquots of positive control lysate (cells with phosphorylated OXSR1)

  • Store these aliquots at -80°C as reference standards

  • With each new experiment, run a positive control lane alongside samples

  • Compare signal intensity with previous results to detect potency changes

• Storage Stability Assessment:

  • Store antibody at -20°C in small working aliquots to minimize freeze-thaw cycles

  • Track number of freeze-thaw cycles for each aliquot

  • Test antibody performance after extended storage (6 months, 12 months)

  • Document any changes in optimal working dilution over time

• Between-Batch Validation:

  • When receiving new antibody lot, perform side-by-side comparison with previous lot

  • Document optimal dilution for each lot

  • Create standardization curve using positive control with serial dilutions

  • Calculate relative potency between lots for accurate protocol adjustment

• Functional Validation:

  • Verify phospho-specificity with phosphatase treatment control

  • Confirm expected molecular weight detection (65-72 kDa)

  • Test antibody response to known stimuli that increase OXSR1 phosphorylation

  • Validate in multiple applications if using across different techniques

This systematic approach to antibody validation ensures experimental reproducibility and facilitates accurate interpretation of results across studies .

How can I design experiments to study the dynamics of OXSR1 phosphorylation in the WNK-SPAK/OSR1 cascade?

To investigate the dynamic regulation of OXSR1 phosphorylation within the WNK-SPAK/OSR1 cascade:

• Temporal Dynamics Analysis:

  • Design high-resolution time course experiments (30 seconds to 24 hours)

  • Use rapid stimulation methods (e.g., stopped-flow apparatus for precise timing)

  • Employ phosphatase inhibitors to capture transient phosphorylation events

  • Implement mathematical modeling to quantify phosphorylation/dephosphorylation kinetics

• Spatial Regulation Studies:

  • Utilize subcellular fractionation to track compartment-specific phosphorylation

  • Employ live-cell imaging with fluorescent biosensors (if available)

  • Perform immunofluorescence with phospho-OXSR1 antibody at different timepoints

  • Analyze proximity to upstream WNK kinases and downstream substrates

• Mechanistic Dissection:

  • Generate phospho-mimetic (T185D/E) and phospho-dead (T185A) OXSR1 mutants

  • Create conditional knockouts of pathway components for temporal control

  • Use chemical genetics with analog-sensitive WNK kinases

  • Apply optogenetic tools for spatiotemporal pathway activation

• Regulatory Feedback Investigation:

  • Examine how OXSR1 phosphorylation affects WNK kinase activity

  • Study the role of phosphatases in pathway termination

  • Investigate scaffold proteins that organize the signaling complex

  • Analyze how downstream substrate phosphorylation feeds back to OXSR1

• Quantitative Analysis Approaches:

  • Employ phosphoproteomics to identify all phosphorylation sites on OXSR1

  • Use FRET/BRET biosensors to monitor conformational changes upon phosphorylation

  • Apply super-resolution microscopy to visualize signaling complexes

  • Implement systems biology approaches to model pathway dynamics

These advanced experimental strategies can provide unprecedented insights into the regulation and function of OXSR1 phosphorylation in diverse physiological contexts .

What approaches can elucidate cross-talk between OXSR1 phosphorylation and other signaling pathways?

To investigate potential cross-talk between OXSR1 phosphorylation and other signaling pathways:

• Multi-Pathway Stimulation/Inhibition:

  • Simultaneously activate WNK pathway and other signaling cascades (MAPK, PI3K/Akt, AMPK)

  • Use specific pathway inhibitors in combination

  • Analyze changes in OXSR1 phosphorylation status when parallel pathways are modulated

  • Create pathway perturbation matrices to identify synergistic or antagonistic effects

• Protein-Protein Interaction Mapping:

  • Perform immunoprecipitation with Phospho-OXSR1 (T185) Antibody followed by mass spectrometry

  • Use proximity labeling techniques (BioID, APEX) to identify interaction partners

  • Employ yeast two-hybrid or mammalian two-hybrid screens with phospho-mimetic OXSR1

  • Validate interactions with microscopy-based methods (FRET, BiFC, PLA)

• Multi-Site Phosphorylation Analysis:

  • Use phosphoproteomics to identify all OXSR1 phosphorylation sites

  • Determine which kinases beyond WNK can phosphorylate OXSR1

  • Create phosphorylation site mutants to study functional consequences

  • Examine hierarchical phosphorylation patterns

• Transcriptional Response Analysis:

  • Perform RNA-seq after OXSR1 activation/inhibition

  • Compare transcriptional signatures with those of other pathways

  • Identify transcription factors regulated by OXSR1 signaling

  • Use chromatin immunoprecipitation to map transcriptional targets

• Systems-Level Integration:

  • Construct comprehensive signaling networks incorporating OXSR1

  • Use mathematical modeling to predict pathway interactions

  • Validate predictions with targeted perturbation experiments

  • Apply machine learning to identify patterns in large datasets

These approaches allow researchers to comprehensively map the integration of OXSR1 signaling within the broader cellular signaling network, revealing novel regulatory mechanisms and potential therapeutic targets .

How can Phospho-OXSR1 (T185) Antibody be applied to translational research in disease models?

Phospho-OXSR1 (T185) Antibody offers valuable applications in translational research across multiple disease contexts:

• Hypertension and Kidney Disease Models:

  • Analyze OXSR1 phosphorylation in kidney tissue from hypertensive animal models

  • Correlate phosphorylation status with sodium-chloride cotransporter (NCC) activity

  • Examine effects of diuretics and antihypertensive drugs on OXSR1 phosphorylation

  • Investigate OXSR1 phosphorylation in kidney biopsies from hypertensive patients

• Neurological Disorders:

  • Study OXSR1-KCC2 regulation in epilepsy models

  • Examine OXSR1 phosphorylation in cerebral edema and stroke models

  • Investigate the role of OXSR1 in neuroprotection against excitotoxicity

  • Analyze OXSR1 activity in neurodevelopmental disorders with ion transport dysregulation

• Cancer Research Applications:

  • Profile OXSR1 phosphorylation across tumor types and stages

  • Correlate with cell migration, invasion, and metastatic potential

  • Examine OXSR1's role in regulating tumor microenvironment osmolarity

  • Investigate potential as therapeutic target or biomarker

• Methodological Approaches:

  • Use tissue microarrays for high-throughput phospho-OXSR1 screening

  • Develop phospho-OXSR1 ELISA for quantitative assessment in clinical samples

  • Apply multiplex immunofluorescence to co-localize with disease markers

  • Employ digital pathology for automated quantification in patient samples

• Therapeutic Development Support:

  • Use phospho-OXSR1 as pharmacodynamic biomarker for WNK-pathway inhibitors

  • Screen compound libraries for modulators of OXSR1 phosphorylation

  • Validate target engagement in preclinical models

  • Develop companion diagnostics for stratifying patients for targeted therapies

These translational applications leverage the specificity of Phospho-OXSR1 (T185) Antibody to bridge fundamental research with clinical applications, potentially leading to novel therapeutic strategies for diseases involving dysregulated ion transport and cell volume regulation .